Familial Amyloid Polyneuropathy

Familial Amyloid Neuropathies (FAP) are a rare group of autosomal dominant diseases in which nerves are compromised due to protein aggregation or fibril formation of transthyretin, apolipoprotein A1, or gelsolin proteins, resulting in nervous system dysfunction. Here is the latest research on these diseases.

January 21, 2021
Open Access

Genomic Screening Identifies Individuals at High Risk for Hereditary Transthyretin Amyloidosis.

Journal of Personalized Medicine
Emily R SoperNoura S Abul-Husn
January 5, 2021
Case Report

A case of cardiac amyloidosis incidentally detected by bone scintigraphy

Asia Oceania Journal of Nuclear Medicine and Biology
Hiroki TanakaKazumi Itoi
December 29, 2020

Early changes of nerve integrity in preclinical carriers of hereditary transthyretin Ala117Ser amyloidosis with polyneuropathy

European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies
Ming-Chang ChiangSung-Tsang Hsieh
December 18, 2020
Open Access

Clinical 3-D Gait Assessment of Patients With Polyneuropathy Associated With Hereditary Transthyretin Amyloidosis

Frontiers in Neurology
Maria do Carmo Vilas-BoasJoão Paulo Silva Cunha
December 18, 2020
Case Report
Open Access

Domino living donor liver transplantation of familial amyloid polyneuropathy patient - A case report

Anesthesia and Pain Medicine
Sungrok ChaGaab Soo Kim
December 29, 2020
Open Access

Cardiac transthyretin amyloidosis 99m Tc-DPD SPECT correlates with strain echocardiography and biomarkers

European Journal of Nuclear Medicine and Molecular Imaging
Viktor LöfbackaTorbjörn Sundström
December 8, 2020
Open Access

Ligand conjugated antisense oligonucleotide for the treatment of transthyretin amyloidosis: preclinical and phase 1 data

ESC Heart Failure
Nicholas J VineyBrett P Monia
January 4, 2021

Tc-99m HMDP bone scintigraphy for cardiac amyloidosis diagnosis: A false positive case

Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
Guillaume LadesJacques Monteil
January 12, 2021
Open Access

Epigenomic Profiles of African American Transthyretin Val122Ile Carriers Reveals Putatively Dysregulated Amyloid Mechanisms

Circulation. Genomic and Precision Medicine
Gita A PathakRenato Polimanti
December 8, 2020
Open Access

Real-world outcomes in non-endemic hereditary transthyretin amyloidosis with polyneuropathy: a 20-year German single-referral centre experience

Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis
Matthias N UngererMarkus Weiler
January 6, 2021
Open Access

Implementing genomic screening in diverse populations

MedRxiv : the Preprint Server for Health Sciences
Noura S Abul-HusnE. E. Kenny
December 6, 2020
Open Access

Pearls and Oy-sters: Number, weaker, and dizzier due to transthyretin amyloidosis after two liver transplants

Alexan I Yerevanian, Francy Shu
January 8, 2021
Open Access

Religious affiliation and COVID-19-related mortality: a retrospective cohort study of prelockdown and postlockdown risks in England and Wales

Journal of Epidemiology and Community Health
Charlotte Hannah GaughanNeil Bannister
January 6, 2021
Open Access

Unravelling the colourful tapestry of hereditary transthyretin amyloid polyneuropathy in Poland

Neurologia i neurochirurgia polska
Elizabeth A Mauricio

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.


TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2021 Meta ULC. All rights reserved